Biography & Research:
Dr. Kelly Dineley attended the University of the Pacific in Stockton, California, where she received her BA in 1983 (Biology) and her MS in 1986 (Cell Biology). In 1998, she received her PhD in Neuroscience from Baylor College of Medicine in Houston, Texas. Following a postdoctoral fellowship in neurobehavior, Dr. Dineley joined the faculty ranks at the University of Texas Medical Branch (UTMB) in 2003. She has steadily funded her research with grants from the National Institutes of Health, the John Sealy Memorial Endowment Fund for Biomedical Research, the Dunn Foundation, the Brown Foundation, Inc., the Alzheimer’s Association, the Bright Focus Foundation, the Peter F. McManus Foundation.
Omics and bioinformatics approaches for the identification of novel systems that underlie memory and cognitive deficits induced by aging, neurodegenerative disease, and drug abuse
Alzheimer’s, Parkinson’s disease, and related proteinopathies: amyloidopathies, tauopathies, synucleinopathies
Cocaine use disorder: translational mechanisms
Animal models utilizing viral, genetic and pharmacological tools for mechanistic and circuit insight
Nicotinic acetylcholine receptors, nuclear receptors (PPAR), ERK MAPK, CREB, CREB binding protein, calcineurin, protein-protein interactions